Compounded Versions of Mounjaro Being Sold at Pharmacies and Spas Prompt Lawsuits
XTalks
SEPTEMBER 21, 2023
The company said it cannot “validate the safety or effectiveness of products claiming to contain tirzepatide that are not our own branded product.” Mounjaro, a dual GLP-1/GIP agonist was approved in May 2022 for type 2 diabetes.
Let's personalize your content